Research on CYP51 continues to evolve, with studies focusing on developing new inhibitors with greater specificity and reduced side effects. Structural studies of CYP51 have provided insights into its active site, guiding the design of novel compounds. Additionally, understanding the genetic basis of resistance can aid in the development of strategies to overcome or prevent it.
